Research of Burden of Interstititial Lung Diseases in Turkey

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03995654

Acronym

RBILD

Enrollment

1000

Registered

2019-06-24

Start date

2019-01-01

Completion date

2021-05-01

Last updated

2021-03-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibrosis Lung, Lung Diseases, Interstitial

Keywords

Interstitial Lung Diseases, Fibrotic Lung, Prevalence

Brief summary

The aim of our study is to investigate the etiological distribution of ILD, epidemiological characteristics of ILD cases such as age, gender, geography, smoking, occupation, economic status, education, and comorbidities. Another aim is to make the cost calculation from the first to the diagnosis in the patients diagnosed. Obtaining the missing data related to the ILD of our country is one of our goals.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Patients who are not previously diagnosed with ILD will be included in the study.

Exclusion criteria

* under 18 years old * older 80 years old

Design outcomes

Primary

Measure	Time frame	Description
Etiological distribution	1 year	The aim of our study is to investigate the etiological distribution of ILD
Epidemiological characteristics of ILD cases	1 year	Age (years)
Total number	1 year	We planned enroll roughly 1000 patients to the study

Secondary

Measure	Time frame	Description
Time	1year	According to the etiology of ILD, the time spent for diagnosis will be presented Time will be presented as months.
Clinical findings	1year	According to the etiology of ILD, clinical findings (Rod, Ral, Rash, Arthritis, Alopecia, Erythema nodosum, Peripheral lymphadenomegaly, Cyanosis, Edema, Raynaud's phenomenon, Other) will be presented as YES or NO and %
Treatment methods	1year	Determining the treatment preferences of physicians according to the etiology of the cases will be presented; Treatment methods are; Non-treatment monitoring, Symptomatic treatment, Systemic corticosteroid, Cytostatic drugs, Antifibrosan drugs (eg Pirfenidone, Nintedanib), Immunological therapy, Referral to other centers, Preparing for transplantation, Home oxygen therapy, Reflux therapy, Other (Methods are will be shown as YES or NO and %)
Pulmonary functions	1year	According to the etiology of ILD, pulmonary functions, will be assessed; FVC (ml) and (%pred)
Diagnostic methods	1year	According to the etiology of ILD, diagnostic methods used in ILD cases will be presented Diagnoses methods are; Clinical and radiology, Bronchoscopic transbronchial lung biopsy, Bronchoalveolar lavage, Transthoracic needle biopsy with imaging, EBUS, VATS, Thoracotomy, Other (Methods are will be shown as YES or NO and %)

Countries

Turkey (Türkiye)

Outcome results